DSL(SH:603233) Zheng Quan Zhi Xing·2025-06-25 18:27Core Viewpoint - The legal opinion issued by King & Wood Mallesons (Guangzhou) Law Firm confirms that the convening and holding of the 2025 First Extraordinary General Meeting of Dazhonglin Pharmaceutical Group Co., Ltd. complies with relevant laws, regulations, and the company's articles of association [1][4][10] Group 1: Meeting Procedures - The meeting was convened on June 25, 2025, and the notice was published in designated media including Securities Daily and the Shanghai Stock Exchange website [3][4] - The meeting took place at the Dazhonglin Group Comprehensive Building, with the presence of a majority of directors, and was chaired by Director Ke Guoqiang [5][6] Group 2: Attendance and Voting - A total of 374 participants attended the meeting, representing 782,247,723 shares, which is 69.0954% of the total voting shares [6][7] - The online voting involved 362 shareholders, representing 86,567,567 shares, accounting for 7.6464% of the total voting shares [7] - The qualifications of attendees were verified, confirming compliance with legal and regulatory requirements [8] Group 3: Voting Procedures and Results - The voting was conducted through a named voting method, with results announced post-voting [9] - The resolutions were passed with 862,239,871 votes in favor (99.2431%), 6,475,995 votes against (0.7453%), and 99,424 abstentions (0.0116%) [9]